Skip to content

Modification of the oral microbiome of periodontal pregnant women and babies after a preventive oral health program during pregnancy

Modification of the oral microbiome of periodontal pregnant women and babies after the implementation of a preventive oral health program during the gestation period

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN94215970
Enrollment
100
Registered
2024-12-27
Start date
2024-04-21
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of complications arising from periodontal disease and improvement of oral health in pregnant periodontal patients, as well as in their babies. Oral Health

Interventions

This is a randomized clinical trial to evaluate the impact of a preventive oral health program in 50 pregnant women with periodontal disease (intervention group) and 50 pregnant women with no interven

Sponsors

Universidad de Murcia
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Pregnancy status: At least 16 weeks of gestation. 2. Screening: Completed screening with all results within normal parameters. 3. Decision to continue the pregnancy: The patient has decided to continue the pregnancy. 4. Diagnosis of periodontal disease: Diagnosed with periodontal disease at stages (I, II, III, IV) and grades (A, B, C) according to Tonetti et al. (2018). 5. Pregnancy risk: Pregnancy is not classified as high risk. 6. Mental health: No significant mental disabilities that would prevent participation in the study or extreme communication difficulties. 7. Informed consent: Acceptance of the informed consent and voluntary participation in the study.

Exclusion criteria

Exclusion criteria: 1. Medical complications 2. Use of medications 3. Obstetric complications 4. History of psychiatric illness 5. Regular smokers or drinkers

Design outcomes

Primary

MeasureTime frame
Pathogenic oral microbiota in pregnant patients and their babies measured in subgingival microbiota samples collected using absorbent paper points inserted into deep periodontal pockets, guided by the CPITN scale (values 3-4) at three time points: during the first appointment (in the 2nd trimester of pregnancy), at the second appointment (end of the 3rd trimester) for all patients, and postpartum (4-5 months later). Additionally, samples of the baby's saliva and a cheek swab will be collected at the postpartum visit using the same absorbent paper points.

Secondary

MeasureTime frame
1. Oral Health-Related Quality of Life measured using test OHIP-14 (Oral Health Impact Profile) at the first visit. 2. Dental Caries measured using the ICDAS Index (Assesses caries detection and severity visually) and CAOD Index (measures decayed, missing, and filled teeth) at the first visit. 3. Periodontal Health measured using the CPI Index (Community Periodontal Index) (Measures periodontal disease severity through probing depths), Silness and Loe bleeding index (based on the observation of bleeding from the gingival margin when gently probing the gums, and it helps to determine the level of gingival inflammation) and O'Leary Plaque Index (Assesses plaque accumulation visually) at the first visit. 4. Baby's Oral Health measured using the Caries Index in Babies: Assesses early dental caries in primary teeth at the visit postpartum. 5. Oral Hygiene Knowledge and Practices measured using Oral hygiene and dietary questionnaires on the first visit. 6. General Health and Sociodemographic Data measured using Medical history and sociodemographic questionnaire at the first visit and last visit postpartum. 7. Obstetric Complications Related to Oral Health measured using Medical history and obstetric follow-up at the first visit and last visit postpartum. 8. Postpartum Follow-Up and Baby's Oral Health measured using Postpartum oral health evaluation at visit postpartum.

Countries

Spain

Contacts

Public ContactElena Sánchez-Guerrero Sánchez
elenasanchezgs2@gmail.com+34 607732177

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Sep 19, 2026